Molson Coors Beverage Company Reports 2025 Third Quarter Results

Executive Summary

• Molson Coors reported a GAAP net loss of $2.93 billion for Q3 2025, driven primarily by a $3.65 billion partial goodwill impairment and intangible asset impairments.
• Net sales declined 2.3% year‑over‑year (reported) and 3.3% in constant currency; financial volume fell 6.0%, while price/mix contributed a modest offset.
• The company reaffirmed full‑year guidance but now expects to finish at the low end of its target ranges for key metrics, including a projected 3–4% decline in net sales (constant currency) and a 7–10% decline in underlying diluted EPS.

Key Details

• Financial Highlights (Q3 2025):
• Net sales: $2.973 billion, down 2.3% YoY (reported) / 3.3% CC.
• GAAP loss before taxes: $(3,495.5) million, a decline of $3,826.9 million vs. prior year due to goodwill and intangible impairments.
• Underlying (Non‑GAAP) income before taxes: $426.0 million, down 11.9% CC.
• GAAP net loss attributable to MCBC: $(2,927.6) million; diluted loss per share $14.79.

• Underlying diluted EPS: $1.67, down 7.2%.

• Impairments & Charges:

• Partial goodwill impairment (Americas reporting unit): $3,645.7 million (including $77.5 million attributable to non‑controlling interests).
• Intangible asset impairments (Blue Run Spirits & Staropramen brands): $273.9 million (incl. $18.9 million NCI).

• Restructuring charges for the nine‑month period: $29.3–$30.0 million.

• Segment Performance:

• Americas: Net sales $2,260.0 million, down 3.6% YoY (reported) / 3.0% CC; financial volume fell 6.5%; underlying income before taxes $387.8 million.

• EMEA & APAC: Net sales $721.0 million, up 2.4% YoY (reported) but down 2.4% CC; underlying income before taxes $89.2 million.

• Cost Structure:

• COGS decreased 2.2% reported, but per‑hectoliter cost rose 4.1% (reported) / 3.7% CC.

• MG&A increased 0.3% reported; underlying MG&A fell 0.6% CC.

• Liquidity & Cash Flow:

• Operating cash provided: $1,243.7 million for the nine‑month period (down $172.1 million YoY).
• Underlying free cash flow: $782.1 million (down $73.9 million YoY).

• Total debt: $6.292 billion; cash & equivalents $950.2 million → net debt $5.342 billion, net‑debt/EBITDA ratio 2.28×.

• Dividends & Share Repurchases:

• Dividends paid: $285.7 million (nine months).

• Share repurchase spend: $332.8 million (nine months).

• 2025 Outlook (Low‑End Guidance):

• Net sales decline 3–4% CC for full year.
• Underlying income before taxes decline 12–15% CC.
• Underlying diluted EPS decline 7–10%.
• Capital expenditures: $650 million ±5%.

• Underlying free cash flow: $1.3 billion ±10%.

• Subsequent Event (Oct 20 2025): Announcement of an Americas restructuring plan eliminating ~400 salaried positions, with expected restructuring charges of $35–$50 million to be incurred in Q4 2025.

Notable Quotes

• Rahul Goyal, President & CEO: “We continue to believe the incremental softness in the industry this year is cyclical… we are well positioned with a healthy balance sheet, strong free cash flow, and great brands…”
• Tracey Joubert, CFO: “Based on these results, we are reaffirming our full‑year guidance, but we now expect to come in at the low end of the ranges for our key metrics.”